Condition: Aortic Regurgitation · Sponsor: Peijia Medical Technology (Suzhou) Co., Ltd.
To evaluate the safety and effectiveness of the TaurusTrio™ Heart Valve System in a patient population with symptomatic severe AR requiring replacement/repair of their native aortic valve that are at high risk for open surgical aortic valve replacement/repair (SAVR).
This description comes directly from the study's public registry record.
jing ren · 18550112597 · renjing@peijiamedical.com
Always discuss trial participation with your own doctor first.
| Beijing Anzhen Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Fu Wai Hospital, Beijing, China | Beijing, Beijing Municipality, China | Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | Recruiting |
| XiaMen Cardiovascular Hospital XiaMen University | Xiamen, Fujian, China | Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| Nanfang Hospital, Southern Medical University | Guangdong, Guangzhou, China | Recruiting |
| The Second Affiliated Hospital of Harbin Medical University | Haerbin, Heilongjiang, China | Recruiting |
| Renmin Hospital of Wuhan University | Wuhan, Hubei, China | Recruiting |
| Wuhan Union Hospital, China | Wuhan, Hubei, China | Recruiting |
| Second Xiangya Hospital of Central South University | Changsha, Hunan, China | Recruiting |
| Nanjing First Hospital | Nanjing, Jiangsu, China | Recruiting |
| The First Affiliated Hospital of Namchang Umiversity | Nanchang, Jiangxi, China | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06101888